These are consistent with our finding that increases in GIP, insulin and C-Peptide were related to decreased volume in regions associated with AD disease pathology, and a growing amount of data are linking insulin and insulin-like growth factor, type 1 (IGF-1) deficiencies to the pathogenesis of AD (de la Monte et al., 2018). Here, INS is linked to Alzheimer disease.